Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Feed Symbols: EXAS

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Fintech
  • Markets
  • News
  • Short Ideas
  • Top Stories
  • Trading Ideas

Cathie Wood Trims Robinhood Stake As Stock Gains 28% In January — Also Offloads Shares In This Biotech Company

By Bhavik Nair
Yesterday, 10:09 PM
Cathie Wood-led ARK Investment Management sold 85,337 shares of financial services company Robinhood Markets Inc (NASDAQ: 

ARKF

Read More
1 minute read
  • Markets
  • Media
  • News
  • Trading Ideas

‘I Think You Should Take The Money And Run’: Cramer On This Stock Up 52% Over Past Month

By Lisa Levin
January 25, 9:53 AM
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Amicus Therapeutics Inc (NASDAQ: FOLD) is an "ideal spec.

ARRY

Read More
3 minute read
  • ETFs
  • News
  • Specialty ETFs
  • Top Stories
  • Trading Ideas

Don’t Call It A Comeback: Cathie Wood Is Beating The S&P 500 In Early 2023

By Chris Katje
January 23, 2:34 PM
The competition could be paying the price in 2023 if Ark Invest can keep up with its early performance at the start of the year.

ARKF

Read More
3 minute read
  • Long Ideas
  • Short Ideas
  • Trading Ideas

Bulls And Bears Of The Week: Tesla, Apple, Microsoft And Dogecoin Millionaire’s Plan To Buy More Cardano

By Michael Cohen
January 14, 3:14 PM
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. 

$ADA

Read More
2 minute read
  • General
  • Health Care
  • Long Ideas
  • Top Stories
  • Trading Ideas

Cathie Wood Makes This Molecular Diagnostics Company Top Holding Of Ark Invest’s Flagship Fund, Catapulting Past Zoom, Tesla

By Shanthi Rexaline
January 11, 12:19 PM
Shares of Exact Sciences, Inc. (NASDAQ: EXAS) have been on a tear, having gained over 27% in two sessions this week.

ARKG

Read More
4 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin
January 9, 2:42 PM
Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.

ALBO

Read More
2 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Tesla, Zillow, Albireo Pharma And Some Other Big Stocks Moving Higher On Monday

By Lisa Levin
January 9, 11:36 AM
U.S. stocks traded higher, with the Dow Jones gaining more than 150 points on Monday. Here are some big stocks recording losses in today’s session.

AGL

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

SVB Leerink Maintains Outperform on Exact Sciences, Raises Price Target to $70

By Benzinga Newsdesk
January 6, 10:04 AM
SVB Leerink analyst Puneet Souda maintains Exact Sciences (NASDAQ:EXAS) with a Outperform and raises the price target from $60 to $70.

EXAS

Read More
2 minute read
  • Long Ideas
  • Technicals
  • Trading Ideas

NYSE Exec: There’s 1 Stock In Cathie Wood’s Fund That’s Ready To Rise (It’s Not Tesla)

By Adam Eckert
January 5, 5:33 PM
As of Thursday, the ARK Innovation ETF (ARCA: ARKK) held 31 stocks. But there's only one name in the entire basket that appeals to Jay Woods, chief market strategist at Drive Wealth and NYSE executive floor director.

ARKK

Read More
2 minute read
  • Broad U.S. Equity ETFs
  • ETFs
  • Long Ideas
  • Markets
  • News
  • Short Ideas
  • Trading Ideas

War, Inflation, Fed Hawkishness, Elon Musk’s Twitter Buy: How These Factors Weighed On Cathie Wood’s Top Holdings In 2022

By Bhavik Nair
January 2, 3:51 AM
In 2022, financial markets witnessed one of the worst routs in history, dragged by the war in Ukraine, rising inflation and subsequent hawkish policies deployed by central banks.

ARKG

Posts navigation

1 2 … 13 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service